Can levofloxacin cause diarrhea?

Can Levofloxacin Cause Diarrhea?

Yes, levofloxacin can cause diarrhea—it is one of the most common adverse reactions, occurring in ≥3% of patients treated with this fluoroquinolone antibiotic 1.

Mechanism and Clinical Significance

Levofloxacin causes diarrhea through two distinct mechanisms:

1. Direct Gastrointestinal Effects (Common, Mild)

• Diarrhea, along with nausea and vomiting, represents the most frequent adverse drug reactions associated with levofloxacin 1
• The overall adverse drug reaction rate for levofloxacin is approximately 2%, which is among the lowest of any fluoroquinolone 2
• These gastrointestinal effects are typically mild and self-limiting 3, 4

2. Clostridium difficile-Associated Diarrhea (Uncommon, Potentially Severe)

Levofloxacin can cause C. difficile-associated diarrhea (CDAD), though it appears to carry a lower risk compared to other antibiotics, particularly beta-lactams 1. The FDA label explicitly warns about this complication, which can range from mild diarrhea to fatal colitis 1.

Comparative Risk Profile

Important clinical distinction: When compared head-to-head with beta-lactam antibiotics for respiratory tract infections, levofloxacin demonstrated a significantly lower incidence of CDAD:

• Levofloxacin: 2.2% CDAD rate
• Beta-lactams overall: 5.6% CDAD rate
• Cefuroxime specifically: 9.2% CDAD rate (P < 0.0001)
• No significant difference versus amoxicillin (1.8%) 5

This suggests that levofloxacin may actually be a safer choice than certain beta-lactams regarding C. difficile risk, particularly compared to cephalosporins.

Clinical Management Approach

When to Suspect CDAD vs. Simple Drug Effect:

• Simple drug-related diarrhea: Mild, occurs early in treatment, resolves with symptomatic management
• CDAD: Can occur during treatment or up to 2 months after antibiotic discontinuation, presents with more severe symptoms, requires specific testing and treatment 1

Action Steps if Diarrhea Develops:

1. Assess severity: Mild diarrhea without systemic symptoms likely represents direct drug effect
2. If severe or persistent: Test for C. difficile toxins A and B
3. If CDAD confirmed: Discontinue levofloxacin (unless treating C. difficile-unrelated critical infection), initiate appropriate fluid/electrolyte management and C. difficile-directed therapy 1

Key Clinical Caveats

• Previous antibiotic exposure is a significant risk factor for CDAD in patients receiving levofloxacin 5
• Patients who develop CDAD have significantly longer hospital stays (25.8 days vs. 11.9 days without CDAD) 5
• In neutropenic hematology-oncology patients receiving prophylactic levofloxacin, the CDI rate was only 3.88% of exposures, with most cases occurring after additional broad-spectrum antibiotics were added 6
• Adequate hydration should be maintained during levofloxacin therapy to prevent crystalluria, though this is unrelated to diarrhea risk 1

Bottom Line for Practice

Diarrhea is an expected, common side effect of levofloxacin that patients should be counseled about. However, levofloxacin appears to carry lower CDAD risk than many alternative antibiotics, particularly cephalosporins. Maintain clinical vigilance for severe or persistent diarrhea that could indicate CDAD, but simple gastrointestinal upset should not automatically prompt discontinuation of this otherwise well-tolerated antibiotic.